Dr. Robert T. Eberhardt, MD

Dr. Eberhardt practices at Boston Medical Center in Boston, Massachusetts, part of Boston Medical Center Health System.

Dr. Eberhardt's NPI, 1912983909, was assigned on December 21, 2005. Dr. Eberhardt graduated from Albert Einstein College of Medicine of Yeshiva University in 1993. Dr. Eberhardt holds Massachusetts license 81054.

Dr. Eberhardt's primary practice is Boston Medical Center, at 1 Boston Medical Center Place, Boston, MA 02118 in Suffolk County. The practice phone is (617) 638-8000.

Dr. Eberhardt's primary practice is Boston Medical Center in Boston, Massachusetts, part of Boston Medical Center Health System. The medical group on file is Boston University Medical Group (Boston University Internal Medicine Associates). Dmand AI also links Dr. Eberhardt to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Eberhardt practices, 2 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Eberhardt's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Eberhardt is licensed in Massachusetts.

CMS data shows 780 Medicare services from Dr. Eberhardt across 15 procedure codes in 2024, for 518 Medicare patients. Medicare paid $28,160 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 518 Medicare patients who saw Dr. Eberhardt in 2024. The largest group is 65 to 74, with 211 patients. 75% of them have high blood pressure, and 73% have high cholesterol. 59% are also on Medicaid. Their average risk score is 2.27, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Eberhardt's median patient age at 62, with 55% women.

In 2024, Dr. Eberhardt wrote 2,497 Medicare Part D claims for 286 patients. 90% of them were for generic drugs. CMS names the drug for 2,381 of them, across 32 drugs with 11 or more claims each, at $296,687 in total drug cost. In 2023, CMS named 2,145 claims across 33 drugs.

Dr. Eberhardt accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Eberhardt as offering telehealth.

Dmand AI links 40 papers to Dr. Eberhardt, published from 2010 to 2024. 2013 was the busiest year, with 4. The most frequent topics are Peripheral Arterial Disease, Chi-Square Distribution and Comorbidity. Dr. Eberhardt has published most often in Ann Vasc Surg. Dr. Eberhardt's most frequent co-authors are Alik Farber, MD, Jeffrey A. Kalish, MD and Joseph D. Raffetto, MD.

CMS Open Payments shows 1 general payment to Dr. Eberhardt from 1 drug or device company in 2016. Food and beverage make up the largest share, 100% of the total. Abbott Laboratories paid the most, $120.

Dr. Eberhardt graduated from Albert Einstein College of Medicine of Yeshiva University in 1993.